UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

Journal of fungi (Basel), 2022-07, Vol.8 (7), p.727

2022

Volltextzugriff (PDF)

In vitro and in vivo anti-Candida activity of citral in combination with fluconazole

Journal of oral microbiology, 2022-12, Vol.14 (1), p.2045813-2045813

2022

Volltextzugriff (PDF)

Assessing pH‐dependent activities of virulence factors secreted by Candida albicans

MicrobiologyOpen (Weinheim), 2023-02, Vol.12 (1), p.e1342-n/a

2023

Volltextzugriff (PDF)

Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

NPJ breast cancer, 2022-11, Vol.8 (1), p.118-8, Article 118

2022

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates

Journal of fungi (Basel), 2023-06, Vol.9 (6), p.648

2023

Volltextzugriff (PDF)

Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients

Journal of clinical medicine, 2022-08, Vol.11 (15), p.4483

2022

Volltextzugriff (PDF)

Project-based learning methodology in the area of microbiology applied to undergraduate medical research

FEMS microbiology letters, 2018-07, Vol.365 (13)

2018

Volltextzugriff (PDF)

Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia

Journal of medical microbiology, 2012, Vol.61 (1), p.80-84

2012

Volltextzugriff (PDF)

Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

The Journal of clinical investigation, 2024-05, Vol.134 (10), p.1-18

2024

Volltextzugriff (PDF)

763 Expanded and activated TILs kill tumor cells enabling IO compound assays

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A457-A457

2020

Volltextzugriff (PDF)

MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer

Clinical & translational oncology, 2022-12, Vol.24 (12), p.2432-2440

2022

Volltextzugriff (PDF)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs

Medicina oral, patología oral y cirugía bucal, 2019-03, Vol.24 (2), p.e172-e180

2019

Volltextzugriff (PDF)

The role of corticoids in the management of advanced prostate cancer.

Archivos españoles de urología, 2018-03, Vol.71 (3), p.281-287

2018

Volltextzugriff (PDF)

Disinfectant Activity of A Portable Ultraviolet C Equipment

International journal of environmental research and public health, 2019-11, Vol.16 (23), p.4747

2019

Volltextzugriff (PDF)

Proteomic profiling of peritoneal fluid-derived exosomes as a tool for the identification of prognostic markers in advanced ovarian carcinomas

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17561-e17561

2023

Volltextzugriff (PDF)

Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study

Journal of clinical oncology, 2015-02, Vol.33 (5), p.465-471

2015

Volltextzugriff (PDF)

Prognostic impact of fibroblast growth factor receptor (FGFR) genomic alterations and outcomes in patients with metastatic urothelial

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.537-537

2022

Volltextzugriff (PDF)

Infigratinib versus placebo in patients with resected urothelial cancer (UC) bearing FGFR3 mutation or fusion: Primary DFS analysis from the phase 3, randomized PROOF302 study

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.629-629

2024

Volltextzugriff (PDF)

Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the ATEZOBLADDERPRESERVE phase II trial (SOGUG-2017-A-IEC(VEJ)-4)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4588-4588

2022

Volltextzugriff (PDF)

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.490-490

2022

Volltextzugriff (PDF)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against ICandida auris/I Isolates

Journal of fungi (Basel), 2023-06, Vol.9 (6)

2023

Volltextzugriff (PDF)

Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses

Medicina oral, patología oral y cirugía bucal, 2020-01, Vol.25 (1), p.e13-e20

2020

Volltextzugriff (PDF)

Clinical outcome in terms of survival and treatment response of patients with metastatic urothelial carcinoma harboring FGFR alterations compared to wild-type tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17042-e17042

2020

Volltextzugriff (PDF)

Abstract 5288: Mechanisms of resistance to FGFR inhibitors in urothelial cancer cell lines and patients harboring FGFR3 alterations and strategies to overcome it

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5288-5288

2020

Volltextzugriff (PDF)

Efficacy of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer (MIBC) (SOGUG-2017-A-IEC(VEJ)-4)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.TPS601-TPS601

2020

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

In vitro and in vivo anti-Candida activity of citral in combination with fluconazole

Assessing pH‐dependent activities of virulence factors secreted by Candida albicans

Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates

Prognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients

Project-based learning methodology in the area of microbiology applied to undergraduate medical research

Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia

Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

763 Expanded and activated TILs kill tumor cells enabling IO compound assays

MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer

Therapeutic tools for oral candidiasis: Current and new antifungal drugs

The role of corticoids in the management of advanced prostate cancer.

Disinfectant Activity of A Portable Ultraviolet C Equipment

Proteomic profiling of peritoneal fluid-derived exosomes as a tool for the identification of prognostic markers in advanced ovarian carcinomas

Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study

Prognostic impact of fibroblast growth factor receptor (FGFR) genomic alterations and outcomes in patients with metastatic urothelial

Infigratinib versus placebo in patients with resected urothelial cancer (UC) bearing FGFR3 mutation or fusion: Primary DFS analysis from the phase 3, randomized PROOF302 study

Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the ATEZOBLADDERPRESERVE phase II trial (SOGUG-2017-A-IEC(VEJ)-4)

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against ICandida auris/I Isolates

Candida albicans biofilms on different materials for manufacturing implant abutments and prostheses

Clinical outcome in terms of survival and treatment response of patients with metastatic urothelial carcinoma harboring FGFR alterations compared to wild-type tumors

Abstract 5288: Mechanisms of resistance to FGFR inhibitors in urothelial cancer cell lines and patients harboring FGFR3 alterations and strategies to overcome it

Efficacy of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer (MIBC) (SOGUG-2017-A-IEC(VEJ)-4)

Suchergebnisse filtern